response

The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change

297 Ertaş, R., Ozyurt, K., Atasoy, M., Hawro, T., and Maurer, M.+: The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change. Allergy 2018: 73; 705-712. IF: 6.77

The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change Read More »

Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion

119. Vestergaard, C., Toubi, E., Maurer, M., Triggiani, M., Ballmer-Weber, B., Marsland, A., Ferrer, M., Knulst, A., and Giménez-Arnau, A.: Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion. Eur. J. Dermatol. 2017: 27; 10-19. IF: 1.94

Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion Read More »